Allyson D. Guidroz's most recent trade in Amedisys Inc. was a trade of 461 Common Stock done at an average price of $96.4 . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.38 per share. | 01 Jul 2025 | 461 | 7,482 (0%) | 0% | 96.4 | 44,431 | Common Stock |
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.07 per share. | 01 Jun 2025 | 171 | 7,943 (0%) | 0% | 94.1 | 16,086 | Common Stock |
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 96.00 per share. | 08 May 2025 | 374 | 8,114 (0%) | 0% | 96 | 35,904 | Common Stock |
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.00 per share. | 03 May 2025 | 273 | 8,488 (0%) | 0% | 96 | 26,208 | Common Stock |
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 92.03 per share. | 04 Mar 2025 | 2,041 | 8,761 (0%) | 0% | 92.0 | 187,833 | Common Stock |
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 2,160 | 11,056 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.60 per share. | 16 Feb 2025 | 254 | 10,802 (0%) | 0% | 92.6 | 23,520 | Common Stock |
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 2,179 | 8,896 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.75 per share. | 25 Jul 2024 | 102 | 6,717 (0%) | 0% | 97.8 | 9,971 | Common Stock |
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.15 per share. | 01 Jun 2024 | 175 | 6,819 (0%) | 0% | 91.1 | 15,951 | Common Stock |
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 2,143 | 7,277 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Allyson D. Guidroz | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.08 per share. | 16 Feb 2024 | 283 | 6,994 (0%) | 0% | 92.1 | 26,059 | Common Stock |